Literature DB >> 31286606

Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.

Caitlin A Knox1, Christian Hampp2, Kristin Palmsten3, Yanmin Zhu1, Soko Setoguchi4, Babette Brumback5, Richard Segal1, Almut G Winterstein1,5.   

Abstract

PURPOSE: The state-assigned Case ID number in the Medicaid Analytic eXtract (MAX) allows for potential linkage of mothers to infants. No validation of respective linkage algorithms is available. We established and validated an algorithm within MAX that links mothers to infants and to identify factors influencing successful mother-infant linkage.
METHODS: We identified all mother-infant pairs in FL and TX birth certificates records (BCR) that could be linked individually to MAX records (1999-2005 for FL and 1999-2010 for TX) based on Social Security Number (gold standard pairs). Case ID linkage performance was evaluated as the proportion of gold standard mother-infant pairs that were identified by the algorithm (sensitivity) and the proportion of algorithm defined mother-infant pairs that were correctly linked. Generalized estimating equations were used to calculate the probability for successful Case ID algorithm linkage versus non-linkage using maternal and infant characteristics.
RESULTS: We identified 323,160 gold standard pairs in FL BCR and MAX and 1,025,350 in TX BCR and MAX. Depending on Medicaid enrollment the algorithm sensitivity ranged from 85.51% to 87.96% in FL and 19.60% to 35.75% in TX. In both states, positive predictive value exceeded 99%, regardless of enrollment periods. Determinants for successful linkage varied across states, but suggested better results for younger mothers, minority women, and those with lower educational achievement.
CONCLUSIONS: Our algorithm can correctly link liveborn infants to their mothers. The algorithm's sensitivity in identifying pairs varied across states, but PPV was consistently high. Linkage performance was associated with certain characteristics that may affect representativeness of successfully linked pairs.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Case ID; Medicaid; pharmacoepidemiology; pregnancy; validation

Mesh:

Year:  2019        PMID: 31286606      PMCID: PMC8756527          DOI: 10.1002/pds.4843

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  14 in total

Review 1.  Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.

Authors:  R J Little; D B Rubin
Journal:  Annu Rev Public Health       Date:  2000       Impact factor: 21.981

2.  Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.

Authors:  Lockwood G Taylor; Rosenie Thelus Jean; Geoff Gordon; David Fram; Trinka Coster
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-03-31       Impact factor: 2.890

3.  Medicaid covered births, 2008 through 2010, in the context of the implementation of health reform.

Authors:  Anne Rossier Markus; Ellie Andres; Kristina D West; Nicole Garro; Cynthia Pellegrini
Journal:  Womens Health Issues       Date:  2013 Sep-Oct

4.  Antidepressant use in pregnancy and the risk of cardiac defects.

Authors:  Krista F Huybrechts; Sonia Hernández-Díaz; Jerry Avorn
Journal:  N Engl J Med       Date:  2014-09-18       Impact factor: 91.245

5.  Internal validation of Medicaid Analytic eXtract (MAX) data capture for comprehensive managed care plan enrollees from 2007 to 2010.

Authors:  Yan Li; Yanmin Zhu; Chao Chen; Xi Wang; Yoonyoung Choi; Carl Henriksen; Almut G Winterstein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-12-06       Impact factor: 2.890

6.  Usability of encounter data for Medicaid comprehensive managed care vs traditional Medicaid fee-for-service claims among pregnant women.

Authors:  Yoonyoung Choi; Haesuk Park; Christian Hampp; Babette Brumback; H Cody Meissner; Yan Li; Dikea Roussos-Ross; Yanmin Zhu; Carl Henriksen; Almut G Winterstein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-11-18       Impact factor: 2.890

7.  Trends in antiretroviral drug use during pregnancy among HIV-infected women on medicaid: 2000-2007.

Authors:  Kelesitse Phiri; Michael A Fischer; Helen Mogun; Paige L Williams; Kristin Palmsten; George R Seage; Sonia Hernandez-Diaz
Journal:  AIDS Patient Care STDS       Date:  2014-02       Impact factor: 5.078

8.  Statins and congenital malformations: cohort study.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts
Journal:  BMJ       Date:  2015-03-17

9.  Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States.

Authors:  Kristin Palmsten; Sonia Hernández-Díaz; Krista F Huybrechts; Paige L Williams; Karin B Michels; Eric D Achtyes; Helen Mogun; Soko Setoguchi
Journal:  BMJ       Date:  2013-08-21

10.  Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.

Authors:  Krista F Huybrechts; Brian T Bateman; Rishi J Desai; Sonia Hernandez-Diaz; Kathryn Rough; Helen Mogun; Leslie S Kerzner; Jonathan M Davis; Megan Stover; Devan Bartels; Jennifer Cottral; Elisabetta Patorno
Journal:  BMJ       Date:  2017-08-02
View more
  1 in total

1.  Oral fluconazole use in the first trimester and risk of congenital malformations: population based cohort study.

Authors:  Yanmin Zhu; Brian T Bateman; Kathryn J Gray; Sonia Hernandez-Diaz; Helen Mogun; Loreen Straub; Krista F Huybrechts
Journal:  BMJ       Date:  2020-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.